GSK acquires oncology research company

GSK acquires the American biotechnology company Idrx for up to 1.15 billion dollars.

Så får du ihop ett CV som imponerar på life science-rekryteraren

På dagens arbetsmarknad är det viktigt att alltid ha ett uppdaterat CV och att skriva ett är inte helt enkelt. Men så länge man har ett konkret mål med sin karr...

Trumps nya FDA-chef varnar för "massiv övermedicinering"

Donald Trump har nominerat kirurgen och författaren Marty Makary till ny chef för den amerikanska läkemedelsmyndigheten FDA, som enligt den tillträdande preside...

Italian pharmaceutical company buys rights to immunotherapy from Sanofi

Italy's Recordati buys the rights to a treatment for the rare autoimmune disease cold agglutinin disease (CAD).

WuXi AppTec, UK Ltd

Compact and leak-tight powerhouse

Media-separated solenoid valve VYKA from Festo is virtually leak-free

How Volume EM Advances Life Science Research

Free webinar series.

Investment CEO: “The Nordics are outstanding in creating successful medtech companies”

in, which companies she believes in the most in the portfolio and why she accepted the new position.

Career coach on salaries: “There is no right or wrong”

What is a reasonable salary for my job? It's a question we all ask ourselves. But how important is a higher salary really? Career coach Tina Persson believes th...

Karriärcoachen om löner: ”Det finns inget rätt eller fel”

Vad är en rimlig lön för mitt jobb? Det är en fråga vi alla ställer oss. Men hur viktigt är det egentligen med högre lön? Det tycker karriärcoachen Tina Persson...

Cost-efficient development of laboratory devices

8 ways to optimise development costs and speed up processes

From powder to implant

Quality assurance for additively manufactured implants.

ZEISS Insights: Measurement of bone plates and screws

Get free access to technical paper.

Mikael Kubista back with new venture after turbulent exit

Entrepreneur and researcher Mikael Kubista is starting a new company. Now he is also free to comment on the sequence of events that led to him losing ownership ...

Roche’s Genentech terminates licencing deal with Norwegian biotech

Genentech is ending a license collaboration with Norwegian biotech Nykode Therapeutics regarding a clinical stage cancer vaccine program.

Astra Zeneca’s Sweden CEO: “We have great faith in our portfolio”

It all started with a summer job as an operator at Astra’s chemical factory in Snäckviken, just outside Södertälje. More than three decades and countless differ...

Quality Assurance for the Highest Medical Standards

Metrology Solutions for Medical Components.

First preterm infants study – a vital step for Neola

After years of developing an advanced lung monitoring system, Neola Medical has received some delightful news: permission to start its first clinical study on p...

Improve your secondary battery manufacturing

SMC provides a large portfolio of products specially designed for secondary battery industry.

Drug development booms in Medicon Valley

When it comes to developing new medicines, the Öresund region is one of the top performers in the EU. Companies working on commission for pharmaceutical compani...

Japanese pharma to buy US drugmaker for $2.4 bln

Japanese Ono Pharmaceutical buys the American cancer drug developer Deciphera Pharmaceuticals in one of the largest acquisitions in the industry so far this year.

Precision and accuracy in liquid handling

How to evaluate and optimize liquid handling performance

On the hunt for high throughput diagnostics

Global diagnostics companies and laboratories are in a race against time to adapt testing capacity to current demand. Due to the global COVID 19 pandemic, the d...

Scale Up Your Image Analysis

ZEISS arivis Hub for accelerated analysis and faster results.